National Presto Industries Subsidiary Wins $49 Million U.S. Army IDIQ Contract for 40mm Ammunition Services

Reuters
Feb 06
National Presto Industries Subsidiary Wins $49 Million U.S. Army IDIQ Contract for 40mm Ammunition Services

National Presto Industries Inc. announced that its wholly owned subsidiary, AMTEC Corporation, has been awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract by the U.S. Army for 40mm Non-Recurring Engineering (NRE) services. The contract, issued on January 30, 2026, includes five ordering periods extending through January 29, 2031, with a maximum ceiling value of $49 million. The agreement covers integration, fabrication, and testing support for 40mm grenade ammunition, as well as assessment of new technologies, improved manufacturing capabilities, and life cycle management. Actual delivery order values will depend on military requirements, funding, and government procurement regulations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. National Presto Industries Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-003213), on February 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10